BSECompany Update6d ago · 24 Aug 2026, 07:38 pm
Completion of tenure of Mr. Rajesh Shashikant Dalal
Entero Healthcare Solutions Ltd · 544122
✦ AI SummaryMgmt Change
Entero Healthcare Solutions Ltd has announced the completion of tenure of Mr. Rajesh Shashikant Dalal as Non-Executive Independent Director, effective August 24, 2026.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Change in Management
Attachments (1)
📄pdf
Download →
794cb6eb-8514-49da-97f2-4155e44eabd4.pdf
View document text
Ref: 36/SE/LC/2026-27 Date: August 24, 2026
Scrip Code BSE: 544122
NSE: ENTERO
ISIN: INE010601016
Head, Listing Compliance Department Head, Listing Compliance Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Dalal Street, Exchange Plaza, Plot No. C/1, G Block,
Mumbai - 400001 Bandra - Kurla Complex, Bandra (East),
Mumbai - 400051
Dear Sir/Madam,
Subject: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 ("SEBI Listing Regulations")
In furtherance of our intimation letters dated July 13, 2026, bearing Reference No.
18/SE/LC/2026-27, and August 07, 2026, bearing Reference No. 30/SE/LC/2026-27, and
pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 ("SEBI Listing Regulations"), this is to inform you that the tenure of Mr. Rajesh
Shashikant Dalal (DIN: 03504969) as Non-Executive Independent Director of the Company
concludes from the close of business hours on August 24, 2026. Accordingly, he ceases to be the
Chairperson of the Nomination and Remuneration Committee, Stakeholders Relationship
Committee and member of the Audit Committee, with effect from the close of business hours on
August 24, 2026.
The Company places on record its sincere appreciation for the valuable guidance and
contribution provided by Mr. Rajesh Shashikant Dalal (DIN: 03504969) during his tenure as Non-
Executive Independent Director of the Company.
The details as required under Regulation 30 of SEBI Listing Regulations read with SEBI Master
Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed
in Annexure-A.
This is for your information and records.
Yours faithfully,
For Entero Healthcare Solutions Limited
Sanu Kapoor
Vice president - Group General Counsel,
Company Secretary & Compliance Officer
Encl: as above
Annexure A
DETAILS IN TERMS OF REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE
REQUIREMENTS) REGULATIONS, 2015 AND SEBI MASTER CIRCULAR NO. HO/49/14/14(7)
2025-CFD-POD2/I/3762/2026
Sr. Particulars Description
1. Reason for change viz. appointment, Completion of tenure of Mr. Rajesh
reappointment, resignation, removal, Shashikant Dalal (DIN: 03504969), as an
death or otherwise. Independent Director of the Company.
2. Date of appointment/re- August 24, 2026.
appointment/cessation (as applicable) &
term of appointment/re-appointment
3. Brief profile Not applicable
4. Disclosure of relationships Not applicable
between Directors